The VF Board of Directors is responsible for setting the strategic direction, policy and agenda for the Vasculitis Foundation. The Board governs on behalf of the VF members and ensures appropriate organizational performance which includes fulfilling the mission of the organization, determining its future direction, and managing the organization’s fiscal health. The Board’s role is to ensure that the VF establishes and maintains the trust of the vasculitis community by being clear in its mission, prudent and ethical in its activities, and accountable for its actions
Jason Wadler, President
Jason joined the VF Board of Directors in 2011 after being diagnosed with GPA/Wegener’s. He has served on the Marketing and Awareness Committees, and his goal is to use his expertise to drive awareness of vasculitis and increase funding for research toward a cure. Jason shared, “I am a big believer in the power of community. Working together, we will have a greater chance of achieving our goals. I look forward to meeting more of the members and levering the power of this passionate community.” Jason is also a co-organizer (with fellow board member, Karen Hirsch) of the annual Chicago Rally in the Alley held each fall. The bowling event brings together patients, families and supporters of the VF to raise awareness of vasculitis and funds for the VF. Jason is Executive Vice President/Strategy Officer for Leapfrog Online, one of the largest digital marketing companies in the country. Since 2000, Jason has delivered leadership, strategy, and innovative ideas and currently leads the company’s corporate marketing and business development efforts. Before his current responsibilities, Jason created and led Leapfrog Online’s Media/Distribution, Research & Analytics and Project Management teams.
Grace Eisen, RN, MSN, Past-president
Lake City, Michigan
Grace was diagnosed with Wegener’s (GPA) in 2004 and joined the VF Board of Directors in 2009. She has been actively involved in the VF as a chapter leader for the SE Michigan Chapter, as an area contact and has co-chaired the Support and Education Council. Grace’s goal is to support and educate patients with vasculitis and their families so they may acquire improved quality of life. Grace serves on the faculty of the MidMichigan Community College Nursing School and before that was a staff nurse. Her professional background and personal experience with vasculitis give her a strong basis to help promote medical awareness and health promotion. She gives presentations to nursing organizations to raise awareness and understanding of vasculitis in the community.
Karen Hirsch, Vice-President, Resource Development
Karen joined the VF Board of Directors in 2012 after a family member was diagnosed with GPA/Wegener’s. She is interested in driving the change to find the cure and improve lives of those with vasculitis through research. Karen has served on the Marketing, and Awareness Committees and in 2013 created the annual V-RED Award, which recognizes the early diagnosis of vasculitis in our patient community. The annual competition seeks nominations from patients honoring the physicians who helped them get diagnosed with vasculitis. She also is co-organizer (with fellow board member, Jason Wadler) of the annual Chicago Rally in the Alley held each fall. The bowling event brings together patients, families and supporters of the VF to raise awareness of vasculitis and funds for the VF. Karen has a background in health care administration and coordinated strategic planning and marketing at Children’s Memorial Hospital and was previously at Rush-Presbyterian St. Luke’s Medical Center and the Illinois Hospital Association. She also serves on the board of the Daughters of Ayacucho Education Foundation and the Skin of Steel Foundation where she focuses on Strategic Planning and Social Media for Skin of Steel.
George Casey, MBA, Treasurer
Highlands Ranch, Colorado
George joined the VF Board of Directors in 2010 and has served as Vice President of Resource Development and currently serves as the treasurer. He was diagnosed with granulomatosis with polyangiitis (Wegener’s, GPA) in 2006. He believes the VF has a great capacity to support and influence patients and caregivers by pooling resources and supporting programs and research at the aggregate level. George is also the co-investigator of the Vasculitis Patient-Powered Research Network (V-PPRN), a partnership of the Vasculitis Foundation, investigators at the University of Pennsylvania and the Vasculitis Clinical Research Consortium (VCRC). The V-PPRN seeks to transform how clinical research in vasculitis is conducted by directly engaging patients, investigators, care providers, and health systems to develop research methods to electronically collect health records and patient-reported data on a large number of patients with various forms of vasculitis. The goal of the V-PPRN research program is to conduct high-quality studies that will improve the care and the health of patients with vasculitis by exploring research questions that matter most to patients and advance medical knowledge about vasculitis. In his professional role, George is the Chief Technology Officer for Junction Solutions, designing and implementing complex business systems for multi-billion dollar organizations. In this role, he directly advises clients on data strategy from both transactional and reporting standpoints, identifying opportunities.
Robert Lebovics, MD, FACS, Treasurer
New York City, New York
Dr. Lebovics joined the VF Board of Directors in 2010. He is a nationally known otolaryngologist with expertise in infectious and inflammatory disorders for adults and children, nasal and sinus surgery, and disorders of the special senses. For almost nine years Dr. Lebovics was Chief of the Clinical Otolaryngology Service at the National Institutes of Health in Bethesda, Maryland. It was there that he oversaw a clinical program that was on the cutting edge of medical innovation and research. Besides ministering to senators, congressmen, and diplomats, he interfaced in the medical frontiers of gene therapy, immunotoxins for treating head and neck cancer, and techniques of surgical rehabilitation for laryngeal and nasal disorders. In 1997, Dr. Lebovics joined the Head and Neck Surgical Group, affiliated with the St. Lukes-Roosevelt Hospital Center with an interest in the medical/surgical treatment of Allergy, Asthma, and Immunology. Dr. Lebovics was Chief of Otolaryngology/Head and Neck Surgery at Cabrini Medical Center in New York City from 1999 through 2002. Among his accomplishments, Dr. Lebovics has authored over 25 articles and textbook chapters in the field of otolaryngology head and neck surgery; most notably included are the ENT chapters in Harrison’s Textbook of Medicine and the Critical Care Medicine textbook.
Chris Cox, MD, Chair, VF Research Committee
Medicine Lake, Minnesota
Dr. Cox joined the VF Board of Directors in 2011 and serves as the chair of the VF Research Committee, which oversees the VF’s Research Program and Fellowship Program. Dr. Cox collaborates with the VF Medical Consultants and Scientific Advisory Board to guide the annual application and selection process of studies and fellowship applicants. She was diagnosed in 2001 with vasculitis, ultimately called atypical Takayasu’s arteritis, and understands the difficulty of diagnosis and effective treatment as well as resulting complications. Before her diagnosis, she practiced neurosurgery affiliated with the University of Minnesota with a subspecialty in epilepsy surgery.
Jeffrey Fishbein, PsyD
Dr. Fishbein was diagnosed with non-systemic micro vasculitis with multiple neuropathies in 2013 and writes the column “Fish’s Focus on Health” for the VF’s bimonthly newsletter and website. He and his family host the annual Chicago Golf Open each year, which helps fund the VCRC-VF Fellowship Program. Dr. Fishbein is a clinical and sports psychologist with Fishbein Performance Consulting in Deerfield, Illinois. He works with individuals, families, athletes and teams on overcoming adversities in their lives, among many other things of course. He teaches others the need to find the positive in an otherwise negative event, to interpret life events optimistically, and to find purpose and meaning in the most uncertain times. As he wrote in his application, “Being a patient allows a unique perspective from which I draw on to enhance the skills above as well as to be empathetic toward the people we are all trying to positively effect.”
Peter Grayson, MD, MSc
Dr. Grayson is the founder and principal investigator of the Translational Program in Vasculitis, established in 2013, and is the associate program director of the NIAMS Rheumatology Fellowship Training Program. He serves as the representative to a major international collaboration to develop novel diagnostic and updated classification criteria in several forms of systemic vasculitis. His research focus includes biomarker discovery and development through gene expression profiling and other genomic techniques, disease classification, clinical epidemiology, and immunology, and clinical trials in vasculitis. Dr. Grayson is also an investigator with the Vasculitis Clinical Research Consortium (VCRC), which is an integrated group of academic medical centers, patient support organizations, and clinical research resources dedicated to conducting clinical research in different forms of vasculitis. It is our goal to improve the care of patients with vasculitis. Click here to watch a video of Dr. Grayson discussing his research.
London, Ontario Canada
Patti was diagnosed with GPA as a young adult almost twenty years ago. Due to subglottic stenosis, she has had over 25 operations on her throat. She has lived and been a patient in Canada, Australia, and England. Patti holds a Masters degree in Creative Writing from Goldsmiths College, London, and she is an immigration lawyer in both England and Canada. Patti is a long-term member of both the Vasculitis Foundation and the Canadian Vasculitis Foundation. She believes her diverse experiences bring a unique perspective to the Board. She is interested in expanding the international outreach of the Vasculitis Foundation and working with the minority communities to raise awareness and understanding of vasculitis.
She lives in London, Ontario, Canada with her husband and young daughter.
Rhonda Byrd Johnson
She was diagnosed with Wegener’s granulomatosis (GPA/Wegener’s) in 1996 and has undergone 25 surgeries, ten infusions with biologics, years of chemotherapy, and has participated in several clinical trials. She enjoys meeting with fellow vasculitis survivors and helping others develop lifestyle coping strategies. She is fond of saying, “I have Wegener’s, but Wegener’s doesn’t have me.” Ms. Byrd is a retired trial attorney. As an equity partner with the Dallas law firm of Thompson, Coe, Cousins & Irons, she headed the Commercial Litigation Section of the firm where she specialized in civil trial work, with a particular emphasis on professional liability, medical malpractice, and product liability/medical device liability litigation. Ms. Byrd has represented Fortune 500 Companies in commercial litigation, pharmaceutical companies in drug product liability suits, breast implant manufacturers in product liability litigation, national insurance companies in bad faith suits, insurance companies’ insureds in personal injury, product liability, and toxic tort cases, and multi-national and foreign corporations in business disputes, including arbitration proceedings before the International Chamber of Commerce (ICC) in Zurich, Switzerland, and tax credit disputes in Buenos Aires, Argentina. She has traveled all over the world practicing law, from Hong Kong to London, and has a national reputation in the U.S. as a litigator for the defense in medical-related cases.
Greg and his wife, Lynn, lost their son, Mark, on March 8, 2009, from Wegener’s granulomatosis. Greg joined the board in 2011 to expand their efforts to raise awareness and understanding of vasculitis on a global basis so that other families don’t lose their loved ones. He and Lynn host informational tables at local health fairs and other venues to raise awareness of vasculitis and the Vasculitis Foundation. Greg serves on the Support and Education Committee as well as the Awareness Month committee. In April 2012 he arranged for fellow board member, Dr. Robert Lebovics, to be the featured guest on the Health and Home Report, a monthly syndicated program which airs nationwide on syndicated cable channels. The interview is one of the most-watched videos on the VF’s YouTube Education Channel.
Steve joined the board in 2004, the same year he was diagnosed with Wegener’s granulomatosis. He has served as treasurer of the board and chaired numerous VF committees including the Marketing, Symposium and Finance committees. He is the founder and director of PRISM, Inc., an international sports marketing and PR company with offices located around the world. PRISM funded the first-ever Vasculitis Fellowship in 2006 and Steve has led efforts to expand the VF’s Fellowship and Research Programs since then.
Paul Monach, MD, PhD
Dr. Monach joined the VF Board of Directors in 2011. He is the director of the Boston University Vasculitis Center and an investigator in the Vasculitis Clinical Research Consortium (VCRC), comprised of several vasculitis centers across North America dedicated to conducting clinical research in vasculitis. Dr. Monach is a rheumatologist and sees patients with all forms of vasculitis. His specific research interests in vasculitis concern biomarkers, genetics, and clinical trials.
Matawan, New Jersey and The Villages, Florida
Bob retired from his position as sales and marketing representative in the textile industry and as former owner of “All About Golf”, a golf accessory distributorship. Bob is now a “Snowbird”; spending summer months in New Jersey and winter months in Florida playing golf with his lovely wife Elaine; a vasculitis survivor since 1999. In addition to being an avid golfer and caregiver to Elaine, Bob, a Vietnam Veteran, spends his retirement years doing volunteer work for the Veterans of Foreign Wars, Kiwanis International, and the Vasculitis Foundation. Bob is past-president of the board and has served on the Support and Education Council as well as the Marketing, Finance and Awareness Committees. Because Elaine’s father also suffered from vasculitis, it is Bob’s belief that vasculitis is not so rare, but because vasculitis is difficult to diagnose, it is rarely diagnosed.
Jason Springer, MD, MS
Kansas City, Kansas
Dr. Springer is an Assistant Professor of Rheumatology and director of the Kansas University Medical Center Vasculitis Clinic. Before starting medical school, his father was diagnosed with vasculitis after developing symptoms of numbness in his feet. Although treated aggressively, he passed away six months after the initial diagnosis and the family was left with many unanswered questions. During Dr. Springer’s residency in Internal Medicine at the University of Utah, he met and worked with Dr. Curry Koening, the director of the Utah Vasculitis Center. Dr. Koening encouraged Dr. Springer to complete his general rheumatology and Vasculitis Fellowship at the Cleveland Clinic Center for Vasculitis Care and Research. In 2013, he joined the KU Medical Center and in 2015 officially opened the KU Vasculitis Clinic. The center provides patient care and also participates in multi-center research studies. Dr. Springer has compiled a team of specialists to care for patients with vasculitis. In July 2014, he hosted a one-day regional conference for patients and family members.